Impact of cadmium exposure on the association between lipopolysaccharide and metabolic syndrome

International Journal of Environmental Research and Public Health

Volumn 12, Issue 9, 2015, Pages 11396-11409

  Han, Seung Jin ^a   Ha, Kyoung Hwa ^a   Jeon, Ja Young ^a   Kim, Hae Jin ^a   Lee, Kwan Woo ^a   Kim, Dae Jung ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Cadmium; Lipopolysaccharide; Metabolic syndrome; Microbes

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CADMIUM; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; POLLUTANT;

BIOME; CADMIUM; CONCENTRATION (COMPOSITION); HEALTH IMPACT; HYPERTENSION; METABOLISM; POLLUTION EXPOSURE; POLYSACCHARIDE;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD PRESSURE MEASUREMENT; CADMIUM BLOOD LEVEL; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROPHOTOMETRY; HUMAN; KOREA; LIPOPOLYSACCHARIDE BLOOD LEVEL; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE; BLOOD; CROSS-SECTIONAL STUDY; ENVIRONMENTAL MONITORING; MICROBIOLOGY; MIDDLE AGED; POLLUTANT; TOXICITY;

ADULT; BIOMARKERS; CADMIUM; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SEX FACTORS; SPECTROPHOTOMETRY, ATOMIC;

EID: 84941335009     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph120911396     Document Type: Article

References (45)

1. Esser, N.; Legrand-Poels, S.; Piette, J.; Scheen, A.J.; Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 2014, 105, 141-150.
2. Suh, S.; Baek, J.; Bae, J.C.; Kim, K.N.; Park, M.K.; Kim, D.K.; Cho, N.H.; Lee, M.K. Sex factors in the metabolic syndrome as a predictor of cardiovascular disease. Endocrinol. Metab. Seoul 2014, 29, 522-529.
3. Cani, P.D.; Osto, M.; Geurts, L.; Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3, 279-288.
4. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 2006, 444, 860-867.
5. Lim, S.; Shin, H.; Song, J.H.; Kwak, S.H.; Kang, S.M.; Won Yoon, J.; Choi, S.H.; Cho, S.I.; Park, K.S.; Lee, H.K.; et al. Increasing prevalence of metabolic syndrome in Korea: The Korean national health and nutrition examination survey for 1998-2007. Diabetes Care 2011, 34, 1323-1328.
6. Jeon, J.Y.; Ha, K.H.; Kim, D.J. New risk factors for obesity and diabetes: Environmental chemicals. J. Diabetes Investig. 2015, 6, 109-111.
7. Sommer, P.; Sweeney, G. Functional and mechanistic integration of infection and the metabolic syndrome. Korean Diabetes J. 2010, 34, 71-76.
8. Allin, K.H.; Nielsen, T.; Pedersen, O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur. J. Endocrinol. Eur. Fed. Endocr. Soc. 2015, 172, 167-177.
9. Musso, G.; Gambino, R.; Cassader, M. Obesity, diabetes, and gut microbiota: The hygiene hypothesis expanded? Diabetes Care 2010, 33, 2277-2284.
10. Hamann, L.; El-Samalouti, V.; Ulmer, A.J.; Flad, H.D.; Rietschel, E.T. Components of gut bacteria as immunomodulators. Int. J. Food Microbiol. 1998, 41, 141-154.
11. Lassenius, M.I.; Pietilainen, K.H.; Kaartinen, K.; Pussinen, P.J.; Syrjanen, J.; Forsblom, C.; Porsti, I.; Rissanen, A.; Kaprio, J.; Mustonen, J.; et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011, 34, 1809-1815.
12. Wendel, M.; Paul, R.; Heller, A.R. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med. 2007, 33, 25-35.
13. Pussinen, P.J.; Tuomisto, K.; Jousilahti, P.; Havulinna, A.S.; Sundvall, J.; Salomaa, V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1433-1439.
14. Jarup, L.; Akesson, A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238, 201-208.
15. Liu, Y.; Li, Y.; Liu, K.; Shen, J. Exposing to cadmium stress cause profound toxic effect on microbiota of the mice intestinal tract. PLoS ONE 2014, 9, doi:10.1371/journal.pone.0085323.
16. Breton, J.; Massart, S.; Vandamme, P.; de Brandt, E.; Pot, B.; Foligne, B. Ecotoxicology inside the gut: Impact of heavy metals on the mouse microbiome. BMC Pharmacol. Toxicol. 2013, 14, doi:10.1186/2050-6511-14-62.
17. Fazeli, M.; Hassanzadeh, P.; Alaei, S. Cadmium chloride exhibits a profound toxic effect on bacterial microflora of the mice gastrointestinal tract. Hum. Exp. Toxicol. 2011, 30, 152-159.
18. Kim, H.J.; Kim, Y.G.; Park, J.S.; Ahn, Y.H.; Ha, K.H.; Kim, D.J. Association between blood glucose level derived using the oral glucose tolerance test and hemoglobin A1C level. Korean J. Intern. Med. 2015, in Press.
19. Nymark, M.; Pussinen, P.J.; Tuomainen, A.M.; Forsblom, C.; Groop, P.H.; Lehto, M. Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care 2009, 32, 1689-1693.
20. Lee, S.Y.; Park, H.S.; Kim, D.J.; Han, J.H.; Kim, S.M.; Cho, G.J.; Kim, D.Y.; Kwon, H.S.; Kim, S.R.; Lee, C.B.; et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res. Clin. Pract. 2007, 75, 72-80.
21. Hooper, L.V.; Midtvedt, T.; Gordon, J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22, 283-307.
22. Savage, D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977, 31, 107-133.
23. Nicholson, J.K.; Holmes, E.; Wilson, I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3, 431-438.
24. Breton, J.; Daniel, C.; Dewulf, J.; Pothion, S.; Froux, N.; Sauty, M.; Thomas, P.; Pot, B.; Foligne, B. Gut microbiota limits heavy metals burden caused by chronic oral exposure. Toxicol. Lett. 2013, 222, 132-138.
25. Satarug, S.; Baker, J.R.; Reilly, P.E.; Moore, M.R.; Williams, D.J. Cadmium levels in the lung, liver, kidney cortex, and urine samples from australians without occupational exposure to metals. Arch. Environ. Health 2002, 57, 69-77.
26. Satarug, S.; Moore, M.R. Emerging roles of cadmium and heme oxygenase in type-2 diabetes and cancer susceptibility. Tohoku J. Exp. Med. 2012, 228, 267-288.
27. Schwartz, G.G.; Il’yasova, D.; Ivanova, A. Urinary cadmium, impaired fasting glucose, and diabetes in the nhanes iii. Diabetes Care 2003, 26, 468-470.
28. Tellez-Plaza, M.; Navas-Acien, A.; Crainiceanu, C.M.; Guallar, E. Cadmium exposure and hypertension in the 1999-2004 national health and nutrition examination survey (NHANES). Environ. Health Perspect. 2008, 116, 51-56.
29. Menke, A.; Muntner, P.; Silbergeld, E.K.; Platz, E.A.; Guallar, E. Cadmium levels in urine and mortality among U.S. Adults. Environ. Health Perspect. 2009, 117, 190-196.
30. Sargis, R.M. The hijacking of cellular signaling and the diabetes epidemic: Mechanisms of environmental disruption of insulin action and glucose homeostasis. Diabetes Metab. J. 2014, 38, 13-24.
31. Srinivasan, P.; Li, Y.H.; Hsu, D.Z.; Su, S.B.; Liu, M.Y. Ostensibly ineffectual doses of cadmium and lipopolysaccharide causes liver damage in rats. Hum. Exp. Toxicol. 2011, 30, 624-635.
32. Satarug, S.; Baker, J.R.; Reilly, P.E.; Esumi, H.; Moore, M.R. Evidence for a synergistic interaction between cadmium and endotoxin toxicity and for nitric oxide and cadmium displacement of metals in the kidney. Nitric Oxide Biol. Chem. Off. J. Nitric Oxide Soc. 2000, 4, 431-440.
33. Everard, A.; Cani, P.D. Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 2013, 27, 73-83.
34. Turner, J.R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009, 9, 799-809.
35. Ley, R.E.; Backhed, F.; Turnbaugh, P.; Lozupone, C.A.; Knight, R.D.; Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070-11075.
36. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022-1023.
37. Hartstra, A.V.; Bouter, K.E.; Backhed, F.; Nieuwdorp, M. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 2015, 38, 159-165.
38. Karlsson, F.H.; Tremaroli, V.; Nookaew, I.; Bergstrom, G.; Behre, C.J.; Fagerberg, B.; Nielsen, J.; Backhed, F. Gut metagenome in Eropean women with normal, impaired and diabetic glucose control. Nature 2013, 498, 99-103.
39. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55-60.
40. Gao, Z.; Yin, J.; Zhang, J.; Ward, R.E.; Martin, R.J.; Lefevre, M.; Cefalu, W.T.; Ye, J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58, 1509-1517.
41. Gnauck, A.; Lentle, R.G.; Kruger, M.C. Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women. Innate Immun. 2015, 21, 537-545.
42. Casimir, G.J.; Heldenbergh, F.; Hanssens, L.; Mulier, S.; Heinrichs, C.; Lefevre, N.; Desir, J.; Corazza, F.; Duchateau, J. Gender differences and inflammation: An in vitro model of blood cells stimulation in prepubescent children. J. Inflamm. Lond. 2010, 7, doi:10.1186/1476-9255-7-28.
43. Santos-Galindo, M.; Acaz-Fonseca, E.; Bellini, M.J.; Garcia-Segura, L.M. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol. Sex Differ. 2011, 2, doi:10.1186/2042-6410-2-7.
44. Soderland, P.; Lovekar, S.; Weiner, D.E.; Brooks, D.R.; Kaufman, J.S. Chronic kidney disease associated with environmental toxins and exposures. Adv. Chronic Kidney Dis. 2010, 17, 254-264.
45. Olsson, I.M.; Bensryd, I.; Lundh, T.; Ottosson, H.; Skerfving, S.; Oskarsson, A. Cadmium in blood and urine—Impact of sex, age, dietary intake, iron status, and former smoking—Association of renal effects. Environ. Health Perspect. 2002, 110, 1185-1190.